Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Pfizer Germany launches Dupuytren’s contracture awareness campaign

Website supports company's novel, first-in-class, biologic Xiapex

Pfizer Germany online Dupuytren's campaign

Pfizer Germany has launched an online campaign to raise awareness of the progressive connective tissue disorder Dupuytren's contracture.

Based around the dupuytren-loesen.de website it offers patients and their families information on the disorder, including a self-test checklist, patient stories and a series of questions to ask their doctor.

Pfizer's novel, first-in-class, biologic Xiapex (collagenase clostridium histolyticum) was approved in Europe last March to treat Dupuytren's contracture and launched in a number of European countries, including Germany, Spain and the UK, during 2011.

The pharma company said its new German online portal would help visitors to understand the disease and give them an over view of the treatment options, with and with surgery, that are available.

Dupuytren's contracture results in a patient's fingers bending towards the palm of their hand, traditionally requiring surgery to straighten them.

The condition most commonly occurs in white Europeans, affecting up to 20 per cent of men over 60 and up to 20 per cent of women over 80.

21st February 2012

From: Marketing

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Lucid Group Communications Limited

WE’RE ON A MISSION To enhance patients’ lives through communication that changes behaviour and improves patient health outcomes....

Latest intelligence

The ALS patient journey
Nick Goldup is the Director of Care Improvement at the Motor Neuron Disease Association (MNDA). Here, he offers his insights into the journey for patients with ALS and explores the...
Equipping your medical affairs teams with solutions to navigate the healthcare landscape
Dr Tyler Ray, OPEN Health Medical Communications...
Protein degraders
Can protein degraders unlock ‘undruggable’ drug targets?
Exploring a new and exciting area of small-molecule drug discovery...

Infographics